Lineage Cell Therapeutics, Inc. Common Stock · Change in Working Capital

Latest reported-$3.97Mperiod endingJun 30, 2026

LCTX Change in Working Capital ($100.00K → -$3.97M)

Annual change in working capital

High-resolution chart · PNG

LCTX change in working capital history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Change in Working Capital — Annual fiscal periods (USD)
Period ending	Change in Working Capital (USD)
Dec 31, 2025	-4,110,000
Dec 31, 2024	-8,766,000
Dec 31, 2023	-10,804,000
Dec 31, 2022	18,669,000
Dec 31, 2021	21,110,000
Dec 31, 2020	1,373,000
Dec 31, 2019	-1,956,000
Dec 31, 2018	638,000
Dec 31, 2017	2,478,000
Dec 31, 2016	-741,000
Dec 31, 2015	3,305,000
Dec 31, 2014	-827,050
Dec 31, 2013	2,725,802
Dec 31, 2012	468,013
Dec 31, 2011	26,122
Dec 31, 2010	-447,763
Dec 31, 2009	-306,100
Dec 31, 2008	1,442,426
Dec 31, 2007	106,959
Dec 31, 2006	269,435
Dec 31, 2005	485,573
Dec 31, 2004	353,543
Dec 31, 2003	126,002
Dec 31, 2002	74,336
Dec 31, 2001	-38,534
Dec 31, 2000	-251,127
Dec 31, 1999	440,369
Dec 31, 1998	100,000
Jun 30, 1998	1,500,000
Jun 30, 1996	-400,000
Jun 30, 1995	400,000
Jun 30, 1994	-100,000
Jun 30, 1993	-100,000
Jun 30, 1992	100,000